medigraphic.com
ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2025, Number 4

Next >>

Rev Latin Infect Pediatr 2025; 38 (4)

Influenza A subclade K

Otero MFJ

Language: Spanish
References: 6
Page: 139-140
PDF size: 179.33 Kb.


ABSTRACT




REFERENCES

  1. Zambon M, Hayden FG. Influenza A(H3N2) subclade K virus: threat and response. JAMA. 2026; 335 (4): 307-310. doi: 10.1001/jama.2025.25903.

  2. Bhatt S, Holmes EC, Pybus OG. The genomic rate of molecular adaptation of the human influenza A virus. Mol Biol Evol. 2011; 28 (9): 2443-2451. doi: 10.1093/molbev/msr044.

  3. Sabaiduc S, Kaweski SE, Separovic L, Gao R, Ranadheera C, Bastien N et al. Emergence of seasonal influenza A(H3N2) variants with immune escape potential warrants enhanced molecular and epidemiological surveillance for the 2025-2026 season. J Assoc Med Microbiol Infect Dis Can [Internet]. 2025; e20250025. Available in: https://doi.org/10.3138/jammi-2025-0025

  4. Ziegler T, Moen A, Zhang W, Cox NJ. Global Influenza Surveillance and Response System: 70 years of responding to the expected and preparing for the unexpected. Lancet. 2022; 400 (10357): 981-982. doi: 10.1016/S0140-6736(22)01741-X.

  5. Cowling BJ, Lin Y, Ikematsu H. Use of influenza antivirals to prevent transmission. J Infect Dis. 2025; 232 (suppl 3): S215-S226. doi: 10.1093/infdis/jiaf116.

  6. Hayden FG, Whitley RJ. Introduction and update: advances in influenza therapeutics. J Infect Dis. 2025; 232 (suppl 3): S169-S176. doi: 10.1093/infdis/jiaf298.




2020     |     www.medigraphic.com